Panel Recommends More Testing for Obesity Drugs

This is the way it should be. The FDA has called for more testing on an obesity drug because of previous effects of other weightloss drugs. Although there are opponents that claim that this will give a huge incentive to not creating obesity drugs, it is definently worth more testing in order to validate its safety. I can see why people really want more drugs because 1/3 of American adults are obese, but extra precautions are good. The past has shown us that similar drugs affected the heart, and cardiovascular system.

Read more at: http://www.nytimes.com/2012/03/30/health/panel-recommends-more-testing-for-obesity-drugs.html?_r=1&ref=health

Written by Jonathan Chang

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s